NCT06826586Active, not recruiting
Identification of Microplastics in Liver, Stomach, Blood, and Feces of Obese Patients and Their Association Analysis with Macrogenomics and Metabolomics.
Source: ClinicalTrials.gov · Last updated 14 Feb 2025
Brief summary (registry, in English)
The aim of this study was to identify and quantify microplastics in the stomach, liver, feces, and blood of obese patients to be treated with bariatric surgery by using a variety of advanced analytical techniques to explore the association between obesity and visceral microplastics, and to investigate the effects of microplastics on the visceral microbiota and metabolic profiles of obese patients by combining the macro-genomic and metabolomics approaches.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 20 (estimated)
- First submitted
- 10 Feb 2025
- Start date
- 1 Dec 2024
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- First Affiliated Hospital of Chongqing Medical University
- Diseases
- Obesity
- NCT number
- NCT06826586
What you commit to
- Study type: Observational
- Planned participants: 20
- From 1 Dec 2024 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receive chemotherapy, radiotherapy, immunotherapy;
Other illness
- have other history of digestive diseases;
- combined with malignant tumors;
- have serious cardiorespiratory insufficiency and other systemic diseases that affect the choice of treatment plan;
Other
- not willing to participate in this study.
Who the study is looking for
- Age ≥18 years old;
- BMI ≧30;
- proposed to undergo bariatric surgery and need to remove part of the liver tissue for fatty liver test;
- complete clinical data and basic information;
- willing to participate in the study and sign the informed consent form.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Chongqing Medical University Coordinator of this site? Confirm its status | Chongqing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.